← back to search

Bertram Klinger

Humboldt-Universität zu Berlin · DE
Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Melanoma and MAPK Pathways, Gene Regulatory Network Analysis, Bioinformatics and Genomic Networks, and Computational Drug Discovery Methods.
h-index
18
citations
2,339
works
55
NIH funding
primary concept
email

Recent publications

Spike-in enhanced phosphoproteomics uncovers synergistic signaling responses to MEK inhibition in colon cancer cells
Nature Communications 2025cited by 5position: middledoi
Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
Cell Death and Disease 2021cited by 72position: middledoi
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance
PLoS Computational Biology 2021cited by 11position: middledoi
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 4position: middledoi
SPEED2: inferring upstream pathway activity from differential gene expression
Nucleic Acids Research 2020cited by 40position: middledoi
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
Cell Reports 2020cited by 35position: middledoi
Neuronal activity regulates alternative exon usage
Molecular Brain 2020cited by 15position: middledoi
Mutation-specific effects of NRAS oncogenes in colorectal cancer cells
Advances in Biological Regulation 2020cited by 12position: middledoi
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Cell Death and Disease 2020cited by 9position: middledoi
An Integrative Genetic, Epigenetic and Proteomic Characterization of Pancreatic Neuroendocrine Neoplasms (PanNENs) defines Distinct Molecular Features of α- and β-cell like Subgroups
2020cited by 3position: middle
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Nature Communications 2019cited by 98position: middledoi
Isoform-specific Ras signaling is growth factor dependent
Molecular Biology of the Cell 2019cited by 34position: middledoi
The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs
Life Science Alliance 2019cited by 16position: middledoi
Modelling signalling networks from perturbation data
Bioinformatics 2018cited by 35position: middledoi
Reverse engineering gene regulatory networks by modular response analysis – a benchmark
Essays in Biochemistry 2018cited by 21position: firstdoi
Comparative Network Reconstruction using mixed integer programming
Bioinformatics 2018cited by 14position: middledoi
Perturbation-response genes reveal signaling footprints in cancer gene expression
Nature Communications 2017cited by 1,114position: middledoi
Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type–Specific Dynamic Logic Models
Cancer Research 2017cited by 110position: middledoi
An immediate–late gene expression module decodes ERK signal duration
Molecular Systems Biology 2017cited by 70position: middledoi
The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Oncogenesis 2017cited by 64position: middledoi
Hypoxia-induced gene expression results from selective mRNA partitioning to the endoplasmic reticulum
Nucleic Acids Research 2015cited by 45position: middledoi
Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A
Oncotarget 2015cited by 22position: middledoi
Consequences of feedback in signal transduction for targeted therapies
Biochemical Society Transactions 2014cited by 18position: firstdoi
Computer-assisted curation of a human regulatory core network from the biological literature
Bioinformatics 2014cited by 10position: middledoi
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Molecular Systems Biology 2013cited by 175position: firstdoi
Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
Molecular Systems Biology 2012cited by 59position: middledoi
Multilevel regulation of HIF-1 signaling by TTP
Molecular Biology of the Cell 2012cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nils Blüthgen · German Cancer Research Center25 papers (2012–2025)Anja Sieber · Humboldt-Universität zu Berlin12 papers (2013–2025)Christine Sers · Humboldt-Universität zu Berlin7 papers (2012–2020)Reinhold Schäfer · Charité - Universitätsmedizin Berlin6 papers (2012–2020)Mathurin Dorel · Max Planck Institute for Molecular Genetics5 papers (2017–2021)Florian Uhlitz · Immunai (United States)5 papers (2017–2020)Markus Morkel · German Cancer Research Center4 papers (2019–2020)Julio Sáez-Rodríguez · European Bioinformatics Institute3 papers (2015–2017)Pamela Riemer · German Cancer Research Center3 papers (2019–2020)Franziska Witzel · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2012–2014)Matthias Selbach · Weatherford College3 papers (2021–2025)David Horst · German Cancer Research Center3 papers (2020–2020)Kathleen Klotz‐Noack · Charité - Universitätsmedizin Berlin3 papers (2020–2020)Mathew J. Garnett · Wellcome Sanger Institute2 papers (2017–2017)Tincy Simon · Humboldt-Universität zu Berlin2 papers (2020–2020)Johannes Zuber · Research Institute of Molecular Pathology2 papers (2020–2020)Anja Bondke Persson · Humboldt-Universität zu Berlin2 papers (2012–2015)Yibing Yan · Anhui Medical University2 papers (2013–2019)Maria Rivera · Beth Israel Deaconess Medical Center2 papers (2020–2020)Mattias Rydenfelt · Charité - Universitätsmedizin Berlin2 papers (2019–2020)